New Phase 2/3 clinical trials: 753 posted since Nov 2024

Name: New Phase 2/3 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Phase 2/3 clinical trials: 753 rows for $37.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 29 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/phase/phase-2-3, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

753 clinical studies in phase 2/3 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 225 have an industry sponsor and 596 are recruiting or about to. The newest, NCT07927075, was posted on November 9, 2026: Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression (Sir Run Run Shaw Hospital).

The request: Every new Phase 2/3 clinical trials on ClinicalTrials.gov, with the sponsor, conditions, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

753New trials
225Industry sponsored
596Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 753, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07927075	Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression	Sir Run Run Shaw Hospital	Phase 2/3	Enrolling by invitation	Colorectal Cancer	17	China	clinicaltrials.gov
November 9, 2026	NCT07927049	Evaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1	Sir Run Run Shaw Hospital	Phase 2/3	Enrolling by invitation	Colorectal Cancer	126	China	clinicaltrials.gov
November 9, 2026	NCT07927010	A Clinical Trial to Evaluate the Efficacy and Safety of Bevemipretide Ophthalmic Topical Solution in Subjects Who Have Dry Age-Related...	Mighty Therapeutics, Inc.	Phase 2/3	Not yet recruiting	Dry AMD, Age-Related Macular Degeneration (AMD)	300		clinicaltrials.gov
November 9, 2026	NCT07926867	A Pilot Multicentric Open Study Assessing the Efficacy and Safety of NEMOlizumab in Patients ≥ 12yo With Dystrophic Epidermolysis Bullosa	Centre Hospitalier Universitaire de Nice	Phase 2/3	Not yet recruiting	Dystrophic Epidermolysis Bullosa	15	France	clinicaltrials.gov
November 6, 2026	NCT07923526	An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic...	United Therapeutics	Phase 2/3	Not yet recruiting	Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease	400	United States	clinicaltrials.gov
November 6, 2026	NCT07923305	Phase 2 and 3 Placebo Controlled & Long-term Extension Study of Rilzabrutinib in Adults With iCVID to Evaluate Efficacy, Safety, and...	Sanofi	Phase 2/3	Not yet recruiting	Immunodeficiency Common Variable	96		clinicaltrials.gov
November 6, 2026	NCT07922226	A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial	Minervax ApS	Phase 2/3	Not yet recruiting	Streptococcus Agalactiae Infection, Neonatal Sepsis, Pneumonia, Meningitis, Neonatal Infection	6,600		clinicaltrials.gov
November 5, 2026	NCT07920549	A Randomized Trial of Standard vs. Hypofractionated Accelerated Radiotherapy for Progression in Limited-Stage Small Cell Lung Cancer	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2/3	Not yet recruiting	Limited Stage Small-Cell Lung Cancer	150	Canada	clinicaltrials.gov
November 5, 2026	NCT07920211	Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental Vitiligo	Teva Branded Pharmaceutical Products R&D LLC	Phase 2/3	Not yet recruiting	Vitiligo	1,020		clinicaltrials.gov
November 5, 2026	NCT07917754	A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)	Merck Sharp & Dohme LLC	Phase 2/3	Not yet recruiting	Lymphoma, Large B-Cell, Diffuse, Diffuse Large B-Cell Lymphoma	470		clinicaltrials.gov
November 4, 2026	NCT07916116	Oral Gabapentin Versus Intravenous Neostigmine/Atropine Versus Combination of Both for Prevention of PDPH	Assiut University	Phase 2/3	Recruiting	Postdural Puncture Headache (PDPH)	292	Egypt	clinicaltrials.gov
November 2, 2026	NCT07908381	A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe...	Enanta Pharmaceuticals, Inc	Phase 2/3	Recruiting	RSV	860	United States	clinicaltrials.gov
October 29, 2026	NCT07903701	A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke	Jiangsu Simcere Pharmaceutical Co., Ltd.	Phase 2/3	Not yet recruiting	Acute Ischemic Stroke AIS	1,092		clinicaltrials.gov
October 29, 2026	NCT07903012	A Split-Face Comparative Study of Mono Threads Versus Combination With Plasma Gel for the Treatment of Post-Acne Scars	Tanta University	Phase 2/3	Enrolling by invitation	Acne	20	Egypt	clinicaltrials.gov
October 28, 2026	NCT07901751	Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)	Ray Therapeutics, Inc.	Phase 2/3	Recruiting	Retinitis Pigmentosa (RP), Inherited Retinal Diseases	60	United States	clinicaltrials.gov
October 28, 2026	NCT07901244	An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease	Biohaven Therapeutics Ltd.	Phase 2/3	Not yet recruiting	Graves' Disease	356		clinicaltrials.gov
October 28, 2026	NCT07900321	Equivalence of Oral Melatonin and Oral Midazolam in Preoperative Anxiolysis for Pediatric Fast-Track Cardiac Surgery	Ain Shams University	Phase 2/3	Active not recruiting	Comparative Effectiveness	100	Egypt	clinicaltrials.gov
October 28, 2026	NCT07900100	Evaluating the Safety and Efficacy of Rupatadine in the Treatment of Nonalcoholic Fatty Liver Disease Patients.	Tanta University	Phase 2/3	Not yet recruiting	NAFLD (Nonalcoholic Fatty Liver Disease)	60	Egypt	clinicaltrials.gov
October 28, 2026	NCT07900087	Evaluating the Safety and Efficacy of Roflumilast in the Treatment of Nonalcoholic Fatty Liver Disease Patients	Tanta University	Phase 2/3	Not yet recruiting	NAFLD (Nonalcoholic Fatty Liver Disease)	60	Egypt	clinicaltrials.gov
October 26, 2026	NCT07895225	PRP Versus NP Injections for Chronic Discogenic Low Back Pain	Walter Reed National Military Medical Center	Phase 2/3	Not yet recruiting	Discogenic Low Back Pain	60	United States	clinicaltrials.gov
October 26, 2026	NCT07893847	Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza	Capital Medical University	Phase 2/3	Not yet recruiting	Influenza, Human	570	China	clinicaltrials.gov
October 23, 2026	NCT07892664	Reducing Arterial Inflammation Using Eplerenone and Statins in HIV	Massachusetts General Hospital	Phase 2/3	Not yet recruiting	HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease	124	United States	clinicaltrials.gov
October 23, 2026	NCT07891156	Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2/3	Recruiting	Type 1 Diabetes, Overweight , Obesity	40	Canada	clinicaltrials.gov
October 22, 2026	NCT07889674	Lactoferrin Nanohydrogel for Soft And Hard Tissue Healing and Implant Stability in Immediate Implant Placement	Future University in Egypt	Phase 2/3	Recruiting	Dental Implant, Wound Healing	20	Egypt	clinicaltrials.gov
October 22, 2026	NCT07888075	Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or...	AVEO Pharmaceuticals, Inc.	Phase 2/3	Not yet recruiting	Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell...	950		clinicaltrials.gov
October 22, 2026	NCT07887984	Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple Myeloma	Alliance for Clinical Trials in Oncology	Phase 2/3	Not yet recruiting	Multiple Myeloma (MM)	920		clinicaltrials.gov
October 21, 2026	NCT07885917	Long-Term Safety and Tolerability of Nizubaglustat in Participants With Rare Lysosomal Disorders	Azafaros B.V.	Phase 2/3	Not yet recruiting	Niemann-Pick Disease Type C, GM2 Gangliosidosis, GM1 Gangliosidosis, Gaucher Disease Type 3	218		clinicaltrials.gov
October 20, 2026	NCT07883928	Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older	GC Biopharma Corp	Phase 2/3	Not yet recruiting	Influenza A, Influenza B, Influenza Vaccination	1,806	South Korea	clinicaltrials.gov
October 19, 2026	NCT07881120	Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus	Beeline Medicines Corporation	Phase 2/3	Recruiting	Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus	390	United States	clinicaltrials.gov
October 19, 2026	NCT07880769	Verapamil In Preclinical Type 1 Diabetes	Assistance Publique - Hôpitaux de Paris	Phase 2/3	Not yet recruiting	Type 1 Diabetes	50	France	clinicaltrials.gov
October 19, 2026	NCT07879599	Neoadjuvant Chemoradiotherapy Plus PD-1 Blockade ± CTLA-4 Blockade for Low/Intermediate-Risk Locally Advanced Rectal Cancer (pMMR/MSS): A...	Yao Hongwei	Phase 2/3	Not yet recruiting	Locally Advanced Rectal Cancer (LARC)	120		clinicaltrials.gov
October 19, 2026	NCT07879586	Neoadjuvant Chemoradiotherapy Plus PD-1 Blockade ± CTLA-4 Blockade for High-Risk Locally Advanced Rectal Cancer (pMMR/MSS): A National...	Yao Hongwei	Phase 2/3	Not yet recruiting	Locally Advanced Rectal Cancer (LARC)	120		clinicaltrials.gov
October 14, 2026	NCT07873996	Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma	Beijing Tiantan Hospital	Phase 2/3	Not yet recruiting	Newly Diagnosed Glioblastoma, IDH-wildtype	60	China	clinicaltrials.gov
October 13, 2026	NCT07870681	Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE	Oslo University Hospital	Phase 2/3	Not yet recruiting	Acute Ischemic Stroke	156	Denmark, Norway	clinicaltrials.gov
October 8, 2026	NCT07866313	Neoadjuvant Chemoradiotherapy Combined With QL1706 for MSS-Type Low-Rectal Cancer	Changhai Hospital	Phase 2/3	Recruiting	MSS-type Low Rectal Cancer，Neoadjuvant Chemoradiotherapy, QL1706	60	China	clinicaltrials.gov
October 8, 2026	NCT07865988	Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients	Menoufia University	Phase 2/3	Completed	Breast Cancer, Radiotherapy Induced Fatigue	51	Egypt	clinicaltrials.gov
October 8, 2026	NCT07865910	A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With...	Shanghai Henlius Biotech	Phase 2/3	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer)	1,438	China	clinicaltrials.gov
October 7, 2026	NCT07863856	Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial	Sherief Ayman Hussein Shaamash	Phase 2/3	Not yet recruiting	Androgenetic Alopecia	40	Egypt	clinicaltrials.gov
October 6, 2026	NCT07861204	Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy	Peking University First Hospital	Phase 2/3	Recruiting	Membranous Nephropathy	90	China	clinicaltrials.gov
October 6, 2026	NCT07860021	VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS)	Thomas Jefferson University	Phase 2/3	Recruiting	Stiff Person Syndrome	26	United States	clinicaltrials.gov
October 5, 2026	NCT07859423	A Study to Investigate AG-236 in Subjects ≥18 Years of Age With Polycythemia Vera	Agios Pharmaceuticals, Inc.	Phase 2/3	Not yet recruiting	Polycythemia Vera	245		clinicaltrials.gov
October 2, 2026	NCT07856329	A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy	Genethon	Phase 2/3	Recruiting	Duchene Muscular Dystrophy	77	Belgium, France, Spain, United Kingdom	clinicaltrials.gov
October 2, 2026	NCT07855770	Use of Preoperative Gas in Eyes With Macula-off Rhegmatogenous Retinal Detachment (RRD)	Wills Eye	Phase 2/3	Not yet recruiting	Retinal Detachment Rhegmatogenous	190	United States	clinicaltrials.gov
October 2, 2026	NCT07853664	Topical Dexamethasone/Diclofenac Hydrogel for Postoperative Pain and Swelling in Facial Soft Tissue Injuries	Thamar University	Phase 2/3	Recruiting	Facial Injuries, Pain, Swelling	52	Yemen	clinicaltrials.gov
October 1, 2026	NCT07852780	Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis	Tanta University	Phase 2/3	Not yet recruiting	Sepsis	80		clinicaltrials.gov
October 1, 2026	NCT07852195	Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer	ECOG-ACRIN Cancer Research Group	Phase 2/3	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	432		clinicaltrials.gov
September 30, 2026	NCT07848672	Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell Mobilization	The Affiliated People's Hospital of Ningbo University	Phase 2/3	Not yet recruiting	Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Hematopoietic Stem Cell Mobilization...	70		clinicaltrials.gov
September 29, 2026	NCT07846865	Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea	Woolcock Institute of Medical Research	Phase 2/3	Not yet recruiting	Sleep Apnoea, Obesity & Overweight, Sleep Apnea Syndrome, Obstructive	256	Australia	clinicaltrials.gov
September 28, 2026	NCT07844356	The Safety and Efficacy of HR19034 in Children With Myopia	Chengdu Suncadia Medicine Co., Ltd.	Phase 2/3	Completed	Slowing the Progression of Myopia in Children	509	China	clinicaltrials.gov
September 25, 2026	NCT07843017	Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia	Copenhagen Respiratory Research	Phase 2/3	Active not recruiting	Community-acquired Pneumonia, CAP, Community Acquired Pneumonia, Pneumonia, Microbial Composition	460	Denmark	clinicaltrials.gov
September 25, 2026	NCT07842796	Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.	Benha University	Phase 2/3	Active not recruiting	Ectopic Pregnancy	144	Egypt	clinicaltrials.gov
September 25, 2026	NCT07842185	A Multicenter, Open-label, Randomized, Non-inferiority Clinical Trial With Blinded Endpoint Assessment of Early Tirofiban After Intravenous...	Xinqiao Hospital of Chongqing	Phase 2/3	Not yet recruiting	Acute Ischemic Stroke	1,192	China	clinicaltrials.gov
September 25, 2026	NCT07842107	Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo	Jean-Pierre Van geertruyden	Phase 2/3	Not yet recruiting	Ebola Hemorrhagic Fever, Bundibugyo Virus Disease	3,620	Democratic Republic of the Congo	clinicaltrials.gov
September 25, 2026	NCT07841470	Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia	Price Vision Group	Phase 2/3	Recruiting	Keratoconus, Corneal Ectasia	500	United States	clinicaltrials.gov
September 25, 2026	NCT07840820	Phase II/III Study of FXS5626 in Participants With Non-segmental Vitiligo	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Phase 2/3	Not yet recruiting	Non-segmental Vitiligo	480	China	clinicaltrials.gov
September 23, 2026	NCT07836972	Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support	Florida International University	Phase 2/3	Not yet recruiting	Attention Deficit Hyerpactivity Disorder	544		clinicaltrials.gov
September 21, 2026	NCT07831824	Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic...	Lantheus Medical Imaging	Phase 2/3	Recruiting	Prostate Cancer	408	United States	clinicaltrials.gov
September 21, 2026	NCT07831746	Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy	UMC Utrecht	Phase 2/3	Not yet recruiting	Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia, Hypoxic-Ischemic Brain Injury, PAIS, HIE - Hypoxic - Ischemic...	162		clinicaltrials.gov
September 21, 2026	NCT07831577	Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis	Genascence Corporation	Phase 2/3	Not yet recruiting	Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis, Knee Arthritis, Knee Arthritis Disease, Osteo Arthritis...	240		clinicaltrials.gov
September 18, 2026	NCT07828002	The GranStone Trial	Martin Blomberg Jensen	Phase 2/3	Not yet recruiting	Paraffinoma, Granuloma, Foreign-Body	100	Denmark	clinicaltrials.gov
September 18, 2026	NCT07827157	Comparison of Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Ultrasound-Guided Erector Spinae Plane Block for Acute...	Assiut University	Phase 2/3	Not yet recruiting	Rib Fractures, Acute Pain, Thoracic Trauma	100		clinicaltrials.gov
September 17, 2026	NCT07825025	The Effectiveness and Safety of Hypertonic Citrate Adenine-New (HCA-N) Solution for the Preservation of Kidney Grafts During Kidney...	Zhongnan Hospital	Phase 2/3	Active not recruiting	Kidney Transplant	250	China	clinicaltrials.gov
September 17, 2026	NCT07824674	The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension	Silvia Ulrich	Phase 2/3	Recruiting	Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)	20	Switzerland	clinicaltrials.gov
September 15, 2026	NCT07820410	Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction	Beijing Anzhen Hospital	Phase 2/3	Recruiting	Heart Failure With Reduced Ejection Fraction (HFrEF)	208	China	clinicaltrials.gov
September 15, 2026	NCT07820085	A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked...	Portal Therapeutics, Inc.	Phase 2/3	Recruiting	Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2	225	United States	clinicaltrials.gov
September 15, 2026	NCT07820046	Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis	Tanta University	Phase 2/3	Recruiting	Ulcerative Colitis (UC)	44	Egypt	clinicaltrials.gov
September 15, 2026	NCT07819435	Phase 2/3 Efficacy and Safety of PP405 in Adult Males	Pelage Pharmaceuticals, Inc.	Phase 2/3	Recruiting	Androgenetic Alopecia	600	Canada, United States	clinicaltrials.gov
September 11, 2026	NCT07815665	A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic...	Summit Therapeutics	Phase 2/3	Recruiting	Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma (UC)	800	United States	clinicaltrials.gov
September 11, 2026	NCT07815236	Diabetes Prevention Through Genetics, Familial History and Behavior Change	Morehouse School of Medicine	Phase 2/3	Not yet recruiting	Prediabetes, Weight Loss	400		clinicaltrials.gov
September 11, 2026	NCT07814664	Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus	Chinese SLE Treatment And Research Group	Phase 2/3	Not yet recruiting	Systemic Lupus Erthematosus	294	China	clinicaltrials.gov
September 10, 2026	NCT07812129	Insulin Eye Drops and Epithelial Healing After Corneal Cross-linking	Cairo University	Phase 2/3	Completed	Corneal Epithelial Wound Healing, Post Operative Pain	24	Egypt	clinicaltrials.gov
September 9, 2026	NCT07811011	Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary Syndrome	Tanta University	Phase 2/3	Not yet recruiting	Poly Cystic Ovary Syndrome	70		clinicaltrials.gov
September 9, 2026	NCT07810998	Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome	Tanta University	Phase 2/3	Not yet recruiting	Poly Cystic Ovary Syndrome	60		clinicaltrials.gov
September 9, 2026	NCT07810556	Intrathecal Dexmedetomidine and Postoperative Delirium in Elderly Hip Fracture Surgery	Assiut University	Phase 2/3	Not yet recruiting	Postoperative Delirium, Hip Fractures	130		clinicaltrials.gov
September 8, 2026	NCT07806565	Naloxone for In-Hospital Cardiac Arrest	Region Skane	Phase 2/3	Not yet recruiting	Heart Arrest	850		clinicaltrials.gov
September 4, 2026	NCT07804849	Oral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 Diabetes	Ain Shams University	Phase 2/3	Recruiting	Type 1 Diabetes Mellitus	70	Egypt	clinicaltrials.gov
September 3, 2026	NCT07801703	Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression	The Royal's Institute of Mental Health Research	Phase 2/3	Recruiting	Treatment Resistant Depression, Major Depressive Disorder (MDD)	60	Canada	clinicaltrials.gov
September 1, 2026	NCT07797036	Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus	University of Massachusetts, Worcester	Phase 2/3	Not yet recruiting	Gestational Diabetes Mellitus (GDM), Metabolic Syndrome	226	United States	clinicaltrials.gov
September 1, 2026	NCT07796399	Comparing Suprascapular Nerve Block and Interscalene Block for Post-thoracotomy Pain in Pediatric Patients.	Children's Cancer Hospital Egypt 57357	Phase 2/3	Recruiting	Nerve Block/Methods	126	Egypt	clinicaltrials.gov
August 28, 2026	NCT07792811	Non-Invasive Deep Brain Stimulation for Upper Limb Recovery After Stroke (NIMBUS)	Friedhelm Hummel	Phase 2/3	Not yet recruiting	Stroke, Stroke Assessment	84	Switzerland	clinicaltrials.gov
August 28, 2026	NCT07792681	Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults	Brise Pharmaceuticals Co., Ltd.	Phase 2/3	Recruiting	Migraine, With or Without Aura	2,079	China	clinicaltrials.gov
August 28, 2026	NCT07791745	A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced...	Taizhou Mabtech Pharmaceutical Co.,Ltd	Phase 2/3	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)	362	China	clinicaltrials.gov
August 26, 2026	NCT07786922	A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard...	Swedish Orphan Biovitrum	Phase 2/3	Not yet recruiting	Aplastic Anemia	26		clinicaltrials.gov
August 25, 2026	NCT07784816	A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis	Hangzhou Highlightll Pharmaceutical Co., Ltd	Phase 2/3	Not yet recruiting	Atopic Dermatitis (AD)	390	China	clinicaltrials.gov
August 18, 2026	NCT07770984	Treatment of CKD Patients With HCV	Tanta University	Phase 2/3	Not yet recruiting	HCV Infection ( Genotype 4) in CKD Patients	50	Egypt	clinicaltrials.gov
August 14, 2026	NCT07765433	Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for...	ECOG-ACRIN Cancer Research Group	Phase 2/3	Not yet recruiting	Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma, Locally Advanced...	336		clinicaltrials.gov
August 13, 2026	NCT07763808	Surgical Treatment for Gingival Recessions After Orthodontic Treatment	Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors	Phase 2/3	Recruiting	Gingival Recessions, Generalized	75	Azerbaijan	clinicaltrials.gov
August 13, 2026	NCT07762248	Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical...	Mohamed Ashraf Abdeen	Phase 2/3	Not yet recruiting	Necrotic Mandibular Molars, Apical Periodontitis	60	Egypt	clinicaltrials.gov
August 12, 2026	NCT07761806	Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction	Ain Shams University	Phase 2/3	Completed	Erectile Dysfunction	75	Egypt	clinicaltrials.gov
August 12, 2026	NCT07761429	A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)	Shandong New Time Pharmaceutical Co., LTD	Phase 2/3	Recruiting	Cancer of Unknown Primary Site	402	China	clinicaltrials.gov
August 11, 2026	NCT07757204	An Open-label Long-term Safety Study of Buntanetap in Participants With AD	Annovis Bio Inc.	Phase 2/3	Not yet recruiting	Alzheimer's Dementia (AD)	400		clinicaltrials.gov
August 11, 2026	NCT07756723	The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic...	Coatesville VA Medical Center	Phase 2/3	Recruiting	Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD)	50	United States	clinicaltrials.gov
August 10, 2026	NCT07756008	Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer	Tianjin Medical University Second Hospital	Phase 2/3	Not yet recruiting	Bladder Urothelial Carcinoma, Muscle-invasive Bladder Cancer, Bladder Cancer	114	China	clinicaltrials.gov
August 10, 2026	NCT07754617	Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis	Rhode Island Hospital	Phase 2/3	Not yet recruiting	Schistosomiasis, Schistosoma Mansoni, Liver Fibrosis, Portal Hypertension	600	Uganda	clinicaltrials.gov
August 6, 2026	NCT07750756	Hyaluronic Acid vs I-PRF With Microneedling in Enhancing Peri-implant Soft Tissue	Ain Shams University	Phase 2/3	Not yet recruiting	Peri-implant Mucosa Thickness	42		clinicaltrials.gov
August 6, 2026	NCT07749300	Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding	Assiut University	Phase 2/3	Not yet recruiting	Acute Upper Gastrointestinal Bleeding, Upper Gastrointestinal Bleeding, Gastrointestinal Hemorrhage	100		clinicaltrials.gov
August 3, 2026	NCT07742553	Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial	VA Office of Research and Development	Phase 2/3	Not yet recruiting	Spinal Cord Injury, Spinal Cord Injuries, Injuries, Spinal Cord, Spinal Cord Contusion, Spinal Cord Trauma, Trauma...	300	United States	clinicaltrials.gov
August 3, 2026	NCT07742280	A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With...	Bostal Drug Delivery Co., Ltd	Phase 2/3	Not yet recruiting	Schizophrenia	16		clinicaltrials.gov
July 31, 2026	NCT07739199	A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific...	Sichuan Baili Pharmaceutical Co., Ltd.	Phase 2/3	Not yet recruiting	Squamous Non-small-cell Lung Cancer	200	China	clinicaltrials.gov
July 31, 2026	NCT07739186	A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as...	Sichuan Baili Pharmaceutical Co., Ltd.	Phase 2/3	Not yet recruiting	Non-squamous Non-small Cell Lung Cancer	166	China	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Tanta University	19	October 29, 2026
Ain Shams University	19	October 28, 2026
Assiut University	13	November 4, 2026
Mansoura University	8	May 8, 2026
Cairo University	7	September 10, 2026
Sichuan Baili Pharmaceutical Co., Ltd.	7	July 31, 2026
Sahiwal medical college sahiwal	7	May 15, 2026
Bristol-Myers Squibb	7	October 27, 2025
Merck Sharp & Dohme LLC	6	November 5, 2026
Nanfang Hospital, Southern Medical University	6	June 9, 2026
AbbVie	6	May 18, 2026
Assistance Publique - Hôpitaux de Paris	5	October 19, 2026
Shanghai Henlius Biotech	5	October 8, 2026
Sun Yat-sen University	5	June 9, 2026
Xiang Luo	5	May 18, 2026
Beni-Suef University	4	July 6, 2026
Peking Union Medical College Hospital	4	June 25, 2026
Pfizer	4	February 6, 2026
Institute of Hematology & Blood Diseases Hospital, China	4	December 12, 2025
Monash University	4	October 1, 2025

Conditions

Condition group	New trials	Latest
Neoplasms	19	October 22, 2026
Carcinoma, Non-Small-Cell Lung	17	October 22, 2026
Ischemic Stroke	15	October 13, 2026
Colorectal Neoplasms	12	November 9, 2026
Leukemia, Myeloid, Acute	12	June 16, 2026
Breast Neoplasms	10	October 8, 2026
Pain, Postoperative	10	September 10, 2026
Recurrence	10	August 28, 2026
Neoplasm Metastasis	10	August 28, 2026
Pain	9	October 2, 2026
Stomach Neoplasms	9	May 22, 2026
Carcinoma, Hepatocellular	9	March 24, 2026
Diabetes Mellitus, Type 1	8	October 23, 2026
Multiple Myeloma	8	October 22, 2026
Precursor Cell Lymphoblastic Leukemia-Lymphoma	8	January 26, 2026
Fatigue	7	October 8, 2026
Prostatic Neoplasms	7	October 1, 2026
Lymphoma	7	September 30, 2026
Parkinson Disease	7	July 24, 2026
Agnosia	7	June 26, 2026
Pancreatic Neoplasms	7	June 18, 2026
Weight Loss	6	October 22, 2026
Osteoarthritis	6	September 21, 2026
Osteoarthritis, Knee	6	July 14, 2026
Depression	6	May 7, 2026

By country

Country	New trials	Latest
China	180	November 9, 2026
United States	168	November 6, 2026
Egypt	81	November 4, 2026
Spain	57	October 2, 2026
Canada	56	November 5, 2026
France	53	November 9, 2026
Australia	46	September 29, 2026
Italy	45	June 8, 2026
United Kingdom	44	October 2, 2026
Poland	38	June 8, 2026
Germany	38	April 29, 2026
Japan	31	June 15, 2026
South Korea	30	October 20, 2026
Belgium	29	October 2, 2026
Brazil	29	April 27, 2026
Israel	25	July 23, 2026
Netherlands	25	May 26, 2026
Taiwan	24	July 14, 2026
Pakistan	22	June 4, 2026
Czechia	21	March 27, 2026
Argentina	20	June 8, 2026
India	19	June 15, 2026
Denmark	17	October 13, 2026
Turkey (Türkiye)	17	June 8, 2026
Austria	17	May 12, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.